ETF Components for BIB - ProShares Ultra Nasdaq Biotechnology


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
GILD B -0.35 7.52
VRTX D -1.10 6.33
AMGN D -1.09 5.61
REGN F -0.31 4.32
AZN F 0.95 3.01
ALNY D -0.17 2.43
BIIB F -0.37 1.87
ILMN C 0.40 1.70
ARGX A -0.90 1.49
UTHR C -0.65 1.30
VTRS A 0.08 1.26
MRNA F -0.97 1.24
INCY C -0.75 1.21
SNY F -0.15 1.16
SMMT D -0.98 1.12
NBIX C 0.57 0.97
BMRN F -1.44 0.96
RPRX D 1.09 0.94
INSM C -1.80 0.93
SRPT F -1.44 0.81
BNTX D 0.40 0.81
EXEL B -0.46 0.80
PCVX D 0.99 0.79
MEDP F 0.00 0.78
RVMD B -0.21 0.74
ITCI B -0.75 0.71
BGNE D 0.71 0.68
ROIV D 1.91 0.67
JAZZ B 1.09 0.59
ASND F -0.79 0.58
MDGL C -0.21 0.54
CYTK D -0.78 0.50
BPMC C -1.58 0.47
HALO F -0.80 0.44
NUVL D -0.55 0.42
KRYS C -1.47 0.41
IONS F -0.68 0.40
ACLX C -1.54 0.39
RNA C -1.97 0.39
ALKS C -0.75 0.37
ADMA B -1.82 0.37
AXSM B -0.38 0.36
CRNX B -0.45 0.35
BBIO F -0.82 0.34
CRSP D -2.86 0.33
RARE F 0.30 0.33
IMVT F -0.55 0.30
GH B 0.75 0.29
RYTM C -1.63 0.29
DNLI D -1.11 0.28
APLS F -2.60 0.26
AGIO C -0.42 0.25
PTCT B -0.36 0.25
MRUS F 1.40 0.25
LEGN D -1.15 0.25
EWTX C 0.31 0.24
XENE D 0.65 0.24
DYN D -1.20 0.24
VCYT B -0.03 0.23
ACAD C -3.56 0.23
FOLD F -1.57 0.23
KYMR D -1.94 0.22
VRNA A -0.05 0.21
IOVA F -1.27 0.21
SWTX C -1.50 0.21
VCEL A 0.10 0.21
TWST F -1.97 0.20
VERA C 1.16 0.20
JANX C -1.84 0.20
GERN C 1.00 0.19
ARWR D -1.87 0.19
PTGX D 4.06 0.19
AMPH F -0.54 0.18
IDYA F -1.12 0.18
KROS D -0.54 0.17
LGND C 0.51 0.17
AKRO C -1.22 0.17
SRRK B -2.03 0.17
SUPN B -0.25 0.16
MIRM B -2.54 0.16
BEAM D -2.00 0.16
MNKD B -1.60 0.15
HRMY F -1.13 0.15
RXRX D -4.62 0.14
FTRE D -0.86 0.14
TARS C -1.98 0.14
NVCR C -1.67 0.14
IRON B 0.95 0.14
ARVN F 1.37 0.13
WVE C -1.19 0.13
XNCR B 0.08 0.12
NTLA F 2.02 0.12
BCRX D -3.77 0.12
DVAX C 1.23 0.12
DAWN D -1.84 0.11
TVTX C 2.52 0.11
SPRY C -2.51 0.11
HROW D -0.33 0.11
OCUL C 0.00 0.11
SNDX F -4.39 0.11
MYGN F 0.65 0.11
NRIX C -1.35 0.11
ARDX F -0.10 0.10
ELVN C -1.89 0.10
INVA D -0.68 0.10
IMCR C -2.07 0.10
KURA F -37.15 0.10
RCKT F -1.92 0.10
ZLAB C 0.00 0.10
NVAX F -0.62 0.10
ARQT B -0.98 0.09
GRFS C -3.26 0.09
CNTA B -2.21 0.09
AUPH C 2.43 0.09
ANIP D 0.00 0.09
COLL F 0.95 0.08
VIR F -1.41 0.08
COGT D 0.39 0.08
ETNB D -1.75 0.07
GMAB F 0.48 0.07
ADPT C -1.70 0.06
PRTA F -0.28 0.06
REPL C -0.71 0.06
PLRX D 0.50 0.06
EOLS F 0.79 0.06
BCYC F -1.77 0.06
PCRX C 1.02 0.06
ERAS C -3.22 0.06
CSTL D 0.26 0.06
CGEM F -3.18 0.06
ABCL D 0.00 0.06
MLYS F -3.73 0.05
ANAB F 0.98 0.05
CVAC F -1.97 0.05
AUTL F -3.39 0.05
ORIC F -0.46 0.05
PHAT F 2.69 0.05
AVXL B -0.18 0.05
IRWD F -4.97 0.05
MRVI F -1.04 0.05
RLAY F -2.47 0.05
ABUS D 0.15 0.05
XERS C -0.49 0.04
FDMT F -6.36 0.04
OABI D 0.00 0.04
ARCT F -3.01 0.04
SIGA F 0.29 0.04
ALLO F -0.73 0.04
TBPH B -2.06 0.04
URGN F -0.83 0.04
TSHA C 1.00 0.04
MGTX C 0.17 0.04
EYPT D 0.00 0.04
THRD D 1.20 0.04
YMAB F -0.14 0.04
SVRA F 2.08 0.04
PAHC B 0.60 0.04
OLMA F -4.95 0.04
RGNX D 0.00 0.04
SANA F -5.34 0.04
HCM C -0.78 0.04
HUMA F -0.45 0.04
GLPG F -1.99 0.04
ACIU D -1.54 0.03
LXRX F -2.61 0.03
ALEC F -3.16 0.03
VERV D -2.20 0.03
PRME F -3.68 0.03
KALV F -2.23 0.03
TERN F -0.89 0.03
RVNC F -0.13 0.03
PACB D 0.58 0.03
AMRN F -0.16 0.02
FULC F -0.67 0.02
EDIT F -4.15 0.02
ZNTL D -2.72 0.02
MGNX D -3.20 0.02
ACRS B 9.60 0.02
PGEN F -0.04 0.02
BMEA F -2.23 0.02
ATAI B -4.09 0.02
LYEL F -1.94 0.02
ITOS F -3.31 0.02
VNDA C -0.71 0.02
SAGE F 2.24 0.02
VYGR F -2.80 0.02
QURE D -2.81 0.02
BLUE F -3.30 0.01
ALXO F 0.00 0.01
OVID D 0.00 0.01
CHRS D -3.56 0.01
VTYX F -1.45 0.01
CABA F -13.05 0.01
CRBU D -1.79 0.01
RAPT F -3.74 0.00

Recent News for ProShares Ultra Nasdaq Biotechnology & its Holdings

Date Stock Title
Nov 21 KURA Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%
Nov 21 VTRS Viatris Inc. (VTRS) Management Presents at Jefferies London Healthcare Conference (Transcript)
Nov 21 HRMY HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
Nov 21 HUMA Humacyte Clinical Results Highlighting Benefit of the ATEV™ in the Repair of Civilian and Military Arterial Injuries Published in JAMA Surgery
Nov 21 AZN We Think AstraZeneca's (LON:AZN) Healthy Earnings Might Be Conservative
Nov 21 JAZZ Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
Nov 21 NVCR Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
Nov 21 NVCR FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
Nov 21 HROW Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.
Nov 21 JAZZ Jazz and Zymeworks announce FDA approval of cancer therapy Ziihera
Nov 21 KURA Kura Oncology partners Kyowa Kirin to advance AML treatment
Nov 21 AZN 3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now
Nov 21 AZN AstraZeneca upgraded to Neutral from Sell at UBS
Nov 21 AZN AstraZeneca price target lowered to EUR 140 from EUR 150 at Berenberg
Nov 21 AUTL AUCATZYL's Approval Positions Autolus Therapeutics Favorably In The CAR-T Market
Nov 21 CRSP CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)
Nov 21 JAZZ Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
Nov 20 KURA Kura stock slides 17% on Kyowa Kirin deal for ziftomenib
Nov 20 KURA Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
Nov 20 ACRS Aclaris upgraded to overweight by Cantor on in-licensing deal
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
Exchange Traded Fund ETF Exchange Traded Funds Stock Market Index Biotechnology Leveraged ETF Ultra ETF Nasdaq 100 Industry Classification Nasdaq Biotechnology Index Nasdaq Biotech Nasdaq Biotechnology Total Return Index
Back to the Main BIB Page...